1242 / 1544
Name I Folie 1 I Datum
Dominant intraprostatic lesion
= cancer-validated areas within the prostate as target for dose escalation
1
Pucar D, et al. IJROBP 2007; 69: 62-69
2
Cellini N, et al. IJROBP 2002; 53: 595–599
3
Coen JJ, et al. JCO 2002; 20: 3199-3205
4
Jacob R, et al. Cancer 2004; 100: 538-543
Clinically significant prostate cancer local recurrence after
radiation therapy occurs at the site of primary tumor
1,2
Relationship: local control - distant metastasis - survival
3,4